Table 2.
Clinical data of patients who underwent both cerebral and hepatic alveolar echinococcosis (AE) operation.
Case no. | Age/ sex | Main symptoms | Cerebral location | Other location | Treatment | Cerebral AE surgery | Degree of cerebral surgery | Duration of ABZ therapy (Regularity) | AE duration (mths)a | Max mRS/ GCS at post-IOp | Time to recurrence | Outcomes (follow-upb) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
8 | 46/M | Epilepsy | Left PO | Liver, Lung | HOp + ABZ +IOp | Left occipital and parietal lobectomy | Completely removed | 3 years (Regular) | 60 mths | 2/15 | 1 mth | Alive (20 mths) |
9 | 49/M | Headache, Dizziness | Left O | Liver, Lung, Kidney | Hop + ABZ + IOp | Left occipital lobectomy | Completely removed | 3 years (Regular) | 72 mths | 0/15 | None | Alive (22 mths) Headache |
13 | 24/F | Headache, Epilepsy, Vomiting | Multiple | Liver, Lung | HOp + ABZ + IOp | Left frontal and occipital lobectomy | Partially removed | 2 years (Regular) | 108 mths | NA | NA | Dead (39 mths) |
18 | 51/F | Headache, Dizziness | Multiple | Liver, Lung | HOp + ABZ +IOp | Left occipital and parietal lobectomy | Partially removed | 1 years (Regular) | 132 mths | NA | NA | Dead (21 mths) |
21 | 69/F | Stomachache | Right thalamus | Liver | ABZ + HOp + IOp | Right thalamic lobectomy | Completely removed | 1 years (Regular) | 24 mths | NA | None | Dead (24 mths) |
F, female; M, male; T, temporal lobe; O, occipital lobe; PO, parieto-occipital lobe; AE, alveolar echinococcosis; IOp, intracranial AE operation; HOp, hepatic AE operation; ABZ, albendazole; Max, maximum; mRS, modifified Rankin Scale; GCS, Glasgow coma scale; mth, month; NA, not applicable.
Course of disease, duration from AE onset until death or last follow-up (months).
Follow-up, duration of follow-up after discharge (months).